All stocks · Financial Services · Insurance Brokers

Arthur J. Gallagher AJG

Arthur J. Gallagher scores weak on business quality (4.1 of 10). Here is why, in plain words, and what our sealed record shows.

Last price$232.70Oct 9, 2026
Business qualityWeak
Next earningsOct 29, 2026, after the close
Insiders, 90 daysSelling

Why it matters

  1. What Arthur J. Gallagher does

    Arthur J. Gallagher & Co. provides insurance brokerage, consulting, and third-party claims settlement services to commercial and institutional clients, earning commissions and fees on risk management. The firm continues its aggressive M&A strategy, recently absorbing Albany Insurance Services Limited to expand its specialty brokerage footprint.

  2. What it does best

    AJG excels at acquiring and integrating boutique brokerages to accelerate top-line expansion, posting a 20.7% revenue growth rate that outpaces peers like MRSH at 10.3%. This roll-up engine relies on deep industry relationships that are difficult for competitors to replicate quickly.

  3. The main risk

    Carrying $13.0 billion in total debt against just $1.2 billion in cash creates a vulnerable balance sheet. With interest coverage sitting at 5.5x, any earnings compression leaves little room to service debt obligations comfortably without straining cash flows.

Quality, check by check

Scored against its own industry, from company filings.

ProfitabilityWeak

Operating margins land at 22.5% while net margin sits near 10.0%, reflecting moderate baseline returns. The business fails to show strong margin expansion as revenue scales rapidly.

MoatWeak

The business lacks a wide structural moat, reflected by a low moat score and an ROE of 6.7% sitting below the sector median. Fragmented insurance broker markets prevent deep ecosystem lock-in.

GrowthFast

Revenue growth surges at 20.7%, driven by aggressive acquisitions like Albany Insurance Services Limited. This rate accelerates well past historical levels, reflecting heavy deal activity.

Financial healthWeak

Total debt of $13.0 billion outweighs cash holdings of $1.2 billion significantly. Free cash flow of $2.3 billion supports operations, but leverage remains heavy and financial footing is softening.

Insiders

Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.

4 sold $7.6M outside pre-planned sales.

Our sealed record on AJG

Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.

The first sealed verdicts appear here on Oct 11, 2026.

Questions

Is AJG a good business?

Arthur J. Gallagher scores weak on the Cluenex quality check (4.1 of 10), measured against its own industry. Profitability is weak, moat weak, growth fast and financial health weak.

Are insiders buying AJG?

In the last 90 days of SEC Form 4 filings: 4 sold $7.6M outside pre-planned sales.

When does AJG report earnings?

Oct 29, 2026, after the close.

For members

See AJG today

  • Today's verdict on AJG, and why
  • Fair value with cautious, base and optimistic cases
  • The exact price that would change the verdict
  • Which stocks each signal names, the night it fires
Open in Cluenex Free to start. First month of Core free.

Cite this page: Cluenex, “Arthur J. Gallagher (AJG)”, https://cluenex.com/stocks/ajg/, data as of Oct 10, 2026.